vasopressin analogue

Terlipressin

US: FDA-approvedEU: Not on the registerUK: AuthorisedCA: Not on the registerAU: RegisteredCH: AuthorisedBR: RegistadoRS: AuthorisedSG: RegisteredTR: Ruhsatli

Answer

Terlipressin is authorised or registered in the US, the UK, Australia, Switzerland, Brazil, Serbia, Singapore and Turkey: 8 of the 10 registers read. Highest trial phase: Phase 3 (2 phase 3 trials, 0 with posted results). It has 118 registered trials, 15 of them running. Brand names on the FDA label register: Terlivaz.

RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03

Not medical, legal or regulatory advice.

Registered trials118Trial register ClinicalTrials.gov and EU CTIS
Running now15Trial register recruiting, active or enrolling
Results posted7Trial register with results on the register
Stopped early8.5%Trial register all peptides: 10%

118 trials by status

Trial register
Running 15Completed 54Stopped early 10Status unknown 36Other or not stated 3

ClinicalTrials.gov and EU CTIS · read 2026-10-03 · 7 trials have posted results

Trials first submitted per year

Trial register

ClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 54 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).

Status by jurisdiction

World map
Authorised or registeredNot on the register, or withdrawnNot read yet, or status unknown
WhereStatusRegisterRead
United StatesFDA-approvedFDA, openfda2026-10-03
European UnionNot on the registerEMA, ema2026-08-31
United KingdomAuthorisedMHRA, uk-mhra2026-10-03
CanadaNot on the registerHealth Canada, ca-dpd2026-09-03
AustraliaRegisteredTGA, au-artg2026-10-03
SwitzerlandAuthorisedSwissmedic, ch-swissmedic2026-10-03
BrazilRegistadoANVISA, br-anvisa2026-10-03
SerbiaAuthorisedALIMS, rs-alims2026-09-03
SingaporeRegisteredHSA, sg-hsa2026-09-03
TurkeyRuhsatliTITCK, tr-titck2026-09-03

An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.

Side effects

Trial register
2 placebo-controlled trials · 293 people on Terlipressin · grey is placebo
Abdominal pain21.8% 13.4%
Diarrhoea16.4% 5.7%
Nausea15% 11.3%
Dyspnoea12.3% 6.7%
Hypotension11.3% 6.7%
ClinicalTrials.gov posted results · read 2026-10-03All side effects

CHANGE ALERTS

Get an email when this changes

One email when the status of Terlipressin changes on the register. You confirm your address first.

REGISTERED TRIALS

Newest 10 of 118 trials

All 118 trials
NCT07252401
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction
not yet recruiting participants · register updated 2026-08-27
NCT07746349
Terlipressin vs Placebo to Reduce Bleeding in Fibroid Surgery
not yet recruiting participants · register updated 2026-08-05
NCT07719933
Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic H
completed · register updated 2026-07-28
NCT02473341
Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial
running, but no longer enrolling · register updated 2026-07-21
NCT06855758
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation
running, but no longer enrolling · register updated 2026-07-13
NCT02970175
Interest of in Situ Terlipressin Administration Before the Realisation of Bronchial Biopsy
completed · register updated 2026-06-08
NCT07304466
Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation
currently recruiting participants · register updated 2026-04-29
NCT04961528
ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.
completed · register updated 2026-04-23
NCT06256432
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
running, but no longer enrolling · register updated 2026-04-13
NCT07178366
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
not yet recruiting participants · register updated 2026-03-25

All peptides · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.